PMI Dividend, Investor Focus
Philip Morris Declares $1.47 Dividend as Institutional Investors Adjust Holdings
Anonymous
Key Points
1
PMI says its smoke-free products are available for sale in “over 105 markets,” and that as of Dec. 31, 2025, they were used by “over 43 million legal-age consumers” worldwide.
2
PMI also points to regulatory approvals: it says the U.S. Food and Drug Administration has authorized marketing of “Swedish Match’s General snus and ZYN nicotine pouches” and “versions of PMI’s IQOS devices and consumables”—describing them as the first such authorizations in their categories.
3
Townsquare Capital’s reduction came with details: it held 34,947 shares after selling 9,769 shares; the stake was worth about $5.605 million, and PMI was about 1.3% of Townsquare’s portfolio (its 20th biggest holding).
4
First American Trust FSB cut its stake from the 4th quarter with specific figures: it owned 38,061 shares after selling 19,428 shares, and the position was worth about $6.105 million at quarter end.
Philip Morris International declared a quarterly dividend of $1.47 per share on June 11, 2026, payable July 20 to shareholders of record as of June 25, according to TradingView. The annualized payout comes to $5.88 per share, extending the company's 18-year streak of dividend increases.
The declaration comes as PMI pushes deeper into smoke-free products — heat-not-burn devices, nicotine pouches, and e-vapor — which now account for 43% of total net revenues as of Q1 2026, according to Markets Financial Content.
Smoke-Free Products Now Drive Nearly Half of Revenue
PMI says its smoke-free products are sold in over 105 markets worldwide. As of December 31, 2025, more than 43 million legal-age consumers used them, according to Weekly Voice. That user base grew as smoke-free revenues climbed from roughly 41.5% of total net revenues in full-year 2025 to 43% in Q1 2026.
PMI's "Value Plan 2030+" targets two-thirds of revenue from smoke-free products by 2030. The company has spent over $16 billion on research and development of non-combustible alternatives since 2008. CEO Jacek Olczak has said the company is "perpetually in motion toward a better future, refusing to stand still."
FDA Approvals Give PMI a Regulatory Edge
The U.S. Food and Drug Administration has authorized marketing of ZYN nicotine pouches, Swedish Match's General snus, and versions of PMI's IQOS heat-not-burn devices — firsts in their product categories, according to Morningstar. In January 2025, ZYN became the first nicotine pouch to receive FDA marketing authorization. In April 2026, the FDA renewed Modified Risk Tobacco Product authorizations for IQOS 2.4 and 3.0 systems.
Not everyone sees the approvals as a win. Public health advocates argue "smoke-free" is a rebrand of addiction. The Campaign for Tobacco-Free Kids has condemned PMI's tactics as designed to "recruit a new generation of users" through sleek designs and influencer marketing. Meanwhile, New York Governor Kathy Hochul has proposed an excise tax on nicotine pouches that could take effect by September 2026, potentially generating $57 million annually by 2030.
Some Institutional Investors Trim Stakes While Others Buy In
Not all institutional investors are adding exposure. Townsquare Capital cut its PMI holdings by 21.8% in Q4 2025, selling 9,769 shares to end the period with 34,947 shares worth about $5.6 million — roughly 1.3% of its portfolio and its 20th-largest holding, according to GuruFocus. First American Trust FSB made a larger cut, selling 19,428 shares to bring its stake to 38,061 shares worth about $6.1 million, a 33.8% reduction.
Others moved in the opposite direction. Assetmark increased its stake by 22.2% to 630,583 shares. Trajan Wealth boosted its holdings by 13.5% to 150,114 shares. Total institutional ownership in PMI stands at 78.63%, according to GuruFocus. Morgan Stanley holds an "Overweight" rating with a $200 price target, while InvestingPro has flagged the stock as "overvalued" despite its long dividend history.
Leadership Transition Adds Uncertainty to Capital Plans
PMI announced in May 2026 that Massimo Andolina will replace Emmanuel Babeau as Group CFO on August 1, 2026. Babeau, who managed the company's finances through the 2022 Swedish Match acquisition, will move to a Strategic Advisor role. Andolina currently serves as President of PMI's Europe Region.
The CFO handoff arrives at a critical moment. PMI's U.S. volumes and profits dipped in Q1 2026 amid supply chain adjustments tied to newer IQOS model rollouts. Analysts at Stifel, who hold a "Buy" rating with a $195 target, say the combustibles business still generates enough cash to fund the smoke-free transition — but the market will be watching Andolina's first moves closely.
Sentiment
Mostly PositiveNEGATIVENEUTRALPOSITIVE
Publishers
13
Articles
17
Reach
30
A
AnonymousAuthor
